CSL
CSL Limited is a global biotherapy industry leader..
Launch date
Employees
Market cap
AUD150.8b
Enterprise valuation
AUD165.3b (Public information from Sep 2024)
Share price
AUD292.86
Company register number 051588348
Parkville Australia (HQ)
Financials
Estimates*
| EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 9.4b | 9.6b | 12.1b | 13.5b | 14.3b | 15.4b | 16.4b |
| % growth | 13 % | 2 % | 26 % | 11 % | 7 % | 7 % | 6 % |
| EBITDA | 3.4b | 3.3b | 3.5b | 4.3b | 4.9b | 5.5b | 6.1b |
| % EBITDA margin | 36 % | 34 % | 29 % | 32 % | 34 % | 36 % | 37 % |
| Profit | 2.2b | 2.1b | 2.0b | 2.4b | 2.8b | 3.3b | 3.7b |
| % profit margin | 23 % | 21 % | 16 % | 18 % | 20 % | 22 % | 23 % |
| EV / revenue | 9.8x | 8.4x | 7.5x | 6.4x | 7.0x | 6.4x | 5.9x |
| EV / EBITDA | 27.2x | 24.6x | 25.6x | 20.0x | 20.3x | 17.9x | 15.9x |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
$18.8b Valuation: $18.8b | Acquisition | ||
| Total Funding | - | ||
